Skip to main content

Table 2 Changes in the urinary albumin/Cr ratio and eGFR

From: T/L-type calcium channel blocker reduces the composite ranking of relative risk according to new KDIGO guidelines in patients with chronic kidney disease

 

Amlodipine group

Benidipine group

P value

 

(n = 50)

(n = 50)

(Amlodipine vs. Benidipine)

Urinary albumin (mg/g • Cr)

   

   Pre

173.2 ± 18.7

175.5 ± 22.4

0.965

   Post

194.1 ± 34.6

120.6 ± 13.6

0.564

   ⊿Urinary albumin

20.8 ± 32.1

-54.9 ± 13.7

0.08

   P value (pre vs. post)

0.774

<0.001

 

eGFR (mL/min/1.73 m2)

   

   Pre

44.7 ± 1.7

44.6 ± 1.9

0.937

   Post

42.7 ± 1.9

44.3 ± 2.1

0.051

   ⊿eGFR

-2.0 ± 0.7

-0.2 ± 0.7

0.032

   P value (pre vs. post)

0.006

0.519

 
  1. Mean ± SEM using the paired t-test or unpaired t-test.